mabcampath
genzyme europe b.v. - alemtuzumab - leukemia, lymphocytic, chronic, b-cell - antineoplastic agents - mabcampath is indicated for the treatment of patients with b-cell chronic lymphocytic leukaemia (bcll) for whom fludarabine combination chemotherapy is not appropriate.
tasermity
genzyme europe bv - sevelamer hydrochloride - hyperphosphatemia; renal dialysis - all other therapeutic products - tasermity is indicated for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis. sevelamer hydrochloride should be used within the context of a multiple therapeutic approach, which could include calcium supplements, 1,25 dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.,
fludara 50mg powder for solution for injection or infusion
genzyme europe bv paasheuvelweg 25, 1105 bp amsterdam , netherlands - fludarabine phosphate - powder for solution for infusion or injection - fludarabine phosphate 25 mg/ml - antineoplastic agents
fludara oral 10mg film-coated tablets
genzyme europe bv paasheuvelweg 25, 1105 bp amsterdam , netherlands - fludarabine phosphate - film-coated tablet - fludarabine phosphate 10 mg - antineoplastic agents
thymoglobuline 25mg powder for solution for infusion
genzyme europe bv paasheuvelweg 25, 1105 bp amsterdam , netherlands - rabbit immunoglobulin - powder for solution for infusion - rabbit immunoglobulin 25 mg - immunosuppressants
kynamro
genzyme europe bv - mipomersen sodium - hypercholesterolemia - cardiovascular system - treatment of cholesterol and hypercholesterolaemia,
fludara 50 mg powder for solution for injection or infusion
genzyme europe b.v. - fludarabine phosphate - powder for solution for injection/infusion - 50 milligram(s) - purine analogues; fludarabine
lemtrada 12 mg concentrate for solution for infusion
genzyme therapeutics ltd - alemtuzumab - concentrate for solution for infusion - 12 mg alemtuzumab in 1.2 ml (10 mg/ml) - multiple sclerosis - selective immunosuppressants - indicated for adult patients with relapsing remitting multiple sclerosis (rrms) with active disease defined by clinical or imaging features
celsior unknown
genzyme europe b.v. - glutathione mannitol lactobionic acid glutamic acid sodium hydroxide calcium chloride 2 h2o potassium chloride magnesium chloride 6 h2o histidine - unknown
fludara 10 mg film-coated tablets
genzyme europe b.v. - fludarabine phosphate - film-coated tablet - 10 milligram(s) - purine analogues; fludarabine